Advertisement Delcath Systems names new board member - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Delcath Systems names new board member

Delcath Systems, a medical technology company specializing in cancer treatment, has appointed Eamonn Hobbs to its board of directors.

Mr Hobbs is president and CEO of AngioDynamics, a medical device company specializing in the development and sales of medical technology serving the needs of interventional oncologists and vascular interventionalists.

Richard Taney, president and CEO of Delcath, said: “We are delighted to have Eamonn join the board of directors of Delcath. His successful leadership of AngioDynamics, his experience within the medical device industry and his involvement in a number of medical organizations make him a welcome addition to our board of directors.”